Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY — Stella

Home/Cardiac Amyloidosis/PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

View on ClinicalTrials.gov

Recruiting

Back to Cardiac Amyloidosis trials

PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Richmond Research Institute, London

Key details

Sponsor

Richmond Research Institute

Collaborators

Richmond Pharmacology Limited, National Amyloidosis Centre

Enrollment target

~320 participants

Started

January 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.